Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information
Phone773 380 6600


I, 1/1989 $9M
II, 1/1993 $31M
III, 1/1996 $107M
IV, 1/1999 $175M
V, 1/2000 $380M
VI, 1/2003 $350M
VII, 1/2007 $400M



Co-Founder and Managing Director
Founder and Managing Director
Founder and Managing Director
Co-founder and Managing Director
Co-Founder and Managing Partner
Co-Founder and Managing Director
Venture Partner
Venture Partner
Show All People


ARCH Venture Partners

ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs, concentrating on bringing to market innovations in life sciences, physical sciences, and information technology. They enjoy special recognition as a leader in the successful commercialization of technologies developed at academic research institutions and national laboratories.

ARCH currently manages seven funds totaling nearly $1.5 billion and has invested in the earliest venture capital rounds for more than 120 companies. ARCH investors include major corporations, pension funds, endowment funds, financial institutions, and private investors.

Recent Milestones


Company Date Round Size Participants
SAGE Therapeutics 3/2014Series C$38M5
Juno Therapeutics 12/2013Series A$120M2
NextCode Health 10/2013Series A$15M2
SAGE Therapeutics 10/2013Series B$20M2
Boreal Genomics 10/2013Series C$18M2
908 Devices 8/2013Series B$7M3
Syros Pharmaceuticals 4/2013Series A$30M2
AgBiome 4/2013Series A$17.5M4
Sorbent Therapeutics 4/2013Venture Round$2.53M2
Siluria Technologies 4/2013Venture Round$3.05M2
TRELYS 4/2013Venture Round$1.25M1
Theraclone Sciences 3/2013Series B$8M8
Achaogen 3/2013Private Equity$18.9M7
nanosys 11/2012Series F$15M2
Quanterix 11/2012Series C$18.5M4
Adesto Technologies 9/2012Series D$14M2
908 Devices 9/2012Series A$8.1M1
Sorbent Therapeutics 8/2012Partial Close$18.1M3
Impinj 7/2012Venture Round$21M6
Siluria Technologies 7/2012Series C$30M9
bluebird bio 7/2012Series D$60M7
Chiasma 7/2012Series D$38.5M3
Cambrios Technologies 7/2012Venture Round$3.93M1
Receptos 3/2012Venture Round$30M6
Semprius 1/2012Venture Round$7.5M3
Groove Biopharma 12/2011Series B$6M4
Agios Pharmaceuticals 11/2011Series C$78M4
Siluria Technologies 9/2011Series B$20M7
Kythera Biopharmaceuticals 9/2011Series D$37.4M7
Shocking Technologies 8/2011Series C$15.2M5
Pulmatrix 8/2011Series B$14M4
Oncofactor Corporation 8/2011Series A$2.1M6
Sorbent Therapeutics 6/2011Series B$36M5
Semprius 6/2011Series C$20M6
Fate Therapeutics 5/2011Series B$36M6
bluebird bio 4/2011Venture Round$30M5
Univa 1/2011Venture Round$7M6
Acylin Therapeutics 1/2011Series A$4.4M4
Siluria Technologies 10/2010Venture Round$13.3M6
Sorbent Therapeutics 9/2010Series B$21.8M4
Crystal IS 8/2010Series B$4M4
Ciespace 8/2010Series A$5M2
Kilimanjaro Energy 8/2010Series A$2.25M1
BIND Therapeutics 6/2010Series C$12.4M4
Adesto Technologies 6/2010Venture Round$3.5M4
Groove Biopharma. 4/2010Series A$3.9M5
Achaogen 4/2010Series C$56M7
Theraclone Sciences 3/2010Series B$1.5M6
Shocking Technologies 2/2010Series B$8M4
VentiRx Pharmaceuticals 1/2010Series A$51.6M4
Innovalight 1/2010Series D$18M8
Receptos 11/2009Series A$25M4
Pulmatrix 11/2009Series B$30.2M4
Cambrios Technologies 11/2009Series D$14.5M14
Innovalight 10/2009Venture Round$15M7
Shocking Technologies 8/2009Series B$10M3
Limerick BioPharma 7/2009Series C$15M3
Semprius 6/2009Series B$6.4M5
Elixir Pharmaceuticals 5/2009Series D$12M5
Lycera 5/2009Series A$36M4
Qwell Pharmaceuticals 1/2009Series A$7M2
Sapphire Energy 9/2008Series D$35M2
Limerick BioPharma 6/2008Venture Round$15.2M3
Sapphire Energy 5/2008Series C$50M2
Kythera Biopharmaceuticals 5/2008Series C$30M9
Univa UD 5/2008Series B$8M5
PhaseRx 2/2008Series A$20.2M3
KOTURA 2/2008Series C$10M5
MediaPhy 2/2008Venture Round$7M2
Fate Therapeutics 11/2007Series A$12M4
Allozyne 10/2007Series B$30M5
Xtera Communications 8/2007Venture Round$52M3
Semprius 7/2007Series A$4.1M3
Shocking Technologies 4/2007Series A$7M2
Impinj 3/2007Series E$19M10
Omeros 2/2007Series E$63M8
Elixir Pharmaceuticals 11/2006Series C$46M6
Chiasma 11/2006Series C$44M4
Aveso 10/2006Series B$6.25M3
Achaogen 10/2006Series B$26M5
Crystal IS 8/2006Series B$10.6M5
Kythera Biopharmaceuticals 7/2006Series B$30M6
AmberWave 7/2006Series E$25M5
Nitronex 6/2006Venture Round$21.8M6
VLST Corporation 6/2006Series B$55M7
Impinj 12/2005Venture Round$26.5M9
Allozyne 12/2005Series A$3.5M4
nanosys 11/2005Series D$41.5M16
KOTURA 9/2005Series B$13M4
Univa UD 8/2005Series A$8M4
Cambrios Technologies 2/2005Series B$12M8
Ahura Scientific 1/2005Series B$10M5
Ensemble Discovery 5/2004Series A$15M3



  1. [edit]
  2. [edit]
  3. [edit]
  4. [edit]
  5. [edit]
  6. [edit]
  7. [edit]
  8. SAGE Therapeutics Completes $38M Series C Financing ( [edit]
  9. Juno Therapeutics Raises $120M in Series A Funding ( [edit]
  10. NextCODE Health Raises $15M in Series A Financing ( [edit]
  11. SAGE Therapeutics Secures $20M Series B Financing ( [edit]
  12. Boreal Genomics Completes $18M Series C Financing ( [edit]
  13. 908 Devices Receives $7 Million in Series B Funding and Signs Multi-Year Development Agreement ( [edit]
  14. Syros Pharmaceuticals Launches with $30 Million Series A Financing ( [edit]
  15. [edit]
  16. VC Funding: Q2 2013 source [edit]
  17. VC Funding: Q2 2013 source [edit]
  18. VC Funding: Q2 2013 source [edit]
  19. Theraclone Sciences Closes $14M in Series B and Debt Financing ( [edit]
  20. VC Funding - Q2 2013 [edit]
  21. Nanosys raises $15M to use ‘quantum dots’ to make displays 50 percent brighter ( [edit]
  22. Quanterix raises $18.5M, inks deal with bioMerieux ( [edit]
  23. SEC ( [edit]
  24. 908 Devices raises $8.1M in Series A round ( [edit]
  25. SEC ( [edit]
  26. Impinj Closes $21M Equity Financing ( [edit]
  27. Siluria Technologies Raises $30 Million in Series C Funding to Commercialize Its Process Technology for Converting Natural Gas Into Commodity Chemicals and Transportation Fuels ( [edit]
  28. bluebird bio Secures $60 Million in Oversubscribed Financing ( [edit]
  29. Chiasma Closes $38.5M Series D Equity Financing ( [edit]
  30. VC Funding: Q3 2012 [edit]
  31. Osage University Partners Source [edit]
  32. CPV Startup Semprius Adds $7.5M to Its War Chest ( [edit]
  33. Groove Biopharma Raises $6M in Series B Financing ( [edit]
  34. Agios Pharmaceuticals Raises $78M in Series C Financing ( [edit]
  35. Siluria Technologies Raises $20M in Series B Financing ( [edit]
  36. KYTHERA Biopharmaceuticals Closed $37.4M Series D Financing ( [edit]
  37. Shocking Technologies raises $15.2M for anti-shock circuit boards ( [edit]
  38. Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis ( [edit]
  39. Oncofactor, Inc.: Series A $2.1M ( [edit]
  40. Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million ( [edit]
  41. Semprius Raises $20M in Series C Venture Funding ( [edit]
  42. SEC ( [edit]
  43. bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team ( [edit]
  44. Univa Closes Additional $7M in Funding ( [edit]
  45. Acylin Therapeutics, Inc.: Series A $4.4M ( [edit]
  46. Kleiner-Backed Siluria Raises Funds for Greener Building Blocks ( [edit]
  47. Sorbent Raises $21.8M Series B, Names New CEO ( [edit]
  48. Crystal IS Taps Investors For $4M To Market Water-Purification LEDs ( [edit]
  49. Ciespace Secures $4 Million Series A for 3D Digital Modeling Software - Names Kevin Kerns as Chief Executive Officer ( [edit]
  50. SEC ( [edit]
  51. Bind banks $12.4M round as lead program heads into PhI Read more: Bind banks $12.4M round as lead program heads into PhI - FierceBiotech ( [edit]
  52. Adesto Technologies brings in $3.5M for memory products ( [edit]
  53. Mirina Nabs $3.9M ( [edit]
  54. Achaogen Completes $56 Million Series C Financing ( [edit]
  55. Theraclone Raises $1.5M ( [edit]
  56. Shocking Raises $8M in Series B-1 Round ( [edit]
  57. VentiRx Pharma Extends Series A To $51.6M ( [edit]
  58. Innovalight Raises $18M, SEC ( [edit]
  59. Receptos raises $25M in Series A ( [edit]
  60. Xconomy Boston ( [edit]
  61. Cambrios lands $14.5M for electronic display components ( [edit]
  62. Solar ink maker Innovalight shines with $15M ( [edit]
  63. Shocking Technologies Secures $10M in Second Round Financing ( [edit]
  64. Limerick lands $15M in Series C ( [edit]
  65. Semprius Lands $6.4M in Funding, Clarifies What It’s Actually Doing ( [edit]
  66. Elixir Pharmaceuticals, Inc.: Series D $12M ( [edit]
  67. Lycera Corp.: Series A $36M ( [edit]
  68. Qwell Pharmaceuticals, Backed by Arch, Raises $7M for New Cancer, Inflammation Drugs ( [edit]
  69. EDGAR [edit]
  70. Limerick BioPharma raises $15.2M for drug bioavailability ( [edit]
  71. Sapphire Energy gets “open checkbook” from investors for algae-based gasoline ( [edit]
  72. Capital Funding Report [edit]
  73. EDGAR [edit]
  74. Biotech Startup PhaseRx Wins $19M Pledge ( [edit]
  75. Industry Leader in Silicon Photonics Raises $10M in Series 3 Funding ( [edit]
  76. Mobile TV chipmaker MediaPhy raises nearly $7 million ( [edit]
  77. Puget Sounds Business Journal ( [edit]
  78. Allozyne, Inc., Closes $30 Million Series B Financing ( [edit]
  79. Xtera raises $52M for optical technology for broadband providers ( [edit]
  80. Semprius Receives Investment from Applied Ventures ( [edit]
  81. Shocking, a semiconductor material company, raises $7M ( [edit]
  83. Omeros Raises More Than $63 Million in Financing ( [edit]
  84. Elixir raises $46M for fountain of youth ( [edit]
  85. Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology. ( [edit]
  86. Aveso Secures $6.25 Million in Series B Funding ( [edit]
  87. Achaogen Closes Series B Financing ( [edit]
  88. Crystal IS, Inc. Raises $10.6 Million in Second Round Financing. ( [edit]
  89. KYTHERA Raises $30 Million In Series B Financing ( [edit]
  90. AmberWave raises $25 million in funds ( [edit]
  91. Nitronex Closes $21.8 Million in Expansion Capital ( [edit]
  92. VLST Corporation Raises $55 Million ( [edit]
  94. Allozyne Inc. Raises $3.5 Million in Series A Funding ( [edit]
  95. EDGAR [edit]
  97. Univa secures $8M to speed its commercial grid software ( [edit]
  98. Cambrios Technology Announces $12 Million Series B Round ( [edit]
  99. Ahura Corporation Raises $10M B-Round to Accelerate Homeland Security Product Offerings ( [edit]
Edit This Page
Last Edited 3/26/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy